IL-6 and Ovarian Cancer--Response

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-2680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Soluble IL-2 Α and Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1994English

P63: Lovastatin Reduces Macrophage IL‐6 and CXCL1 Production in an Ovarian TAM‐like Model Reducing Ovarian Cancer Cell Invasion

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

IL-6; IL-6 Receptor (CD126)

Science-Business eXchange
2009English

Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor

Journal of Neuroscience
Neuroscience
1999English

Inhibition of MK2 Suppresses IL-1β, IL-6, and TNF-α Dependent Colorectal Cancer Growth

International Journal of Cancer
Cancer ResearchOncology
2017English

TGF-β1 and IL-10 Expression in Epithelial Ovarian Cancer Cell Line A2780

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

Potential Therapeutic Implications of IL-6/IL-6R/gp130-targeting Agents in Breast Cancer

Oncotarget
Oncology
2016English

The Role of Interleukin-8 (IL-8) and IL-8 Receptors in Platinum Response in High Grade Serous Ovarian Carcinoma

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy